These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2847206)

  • 41. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3H-imipramine binding in the frontal cortex of suicides.
    Arora RC; Meltzer HY
    Psychiatry Res; 1989 Nov; 30(2):125-35. PubMed ID: 2559421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phototherapy increases platelet 3H-imipramine binding in patients with winter depression.
    Szádóczky E; Falus A; Arató M; Németh A; Teszéri G; Moussong-Kovács E
    J Affect Disord; 1989; 16(2-3):121-5. PubMed ID: 2537860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of seasonal variation in platelet [3H]imipramine binding in humans.
    Galzin AM; Lôo H; Sechter D; Langer SZ
    Biol Psychiatry; 1986 Aug; 21(10):876-82. PubMed ID: 3017462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Capgras syndrome-a biochemical marker?
    Sullivan JL; Cavenar JO; Maltbie AA; Silverstein E
    J Nerv Ment Dis; 1978 Apr; 166(4):275-9. PubMed ID: 650189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of neuronal MAO activity, 5-HT uptake and imipramine binding by endogenous substances in dog cerebrospinal fluid.
    Egashira T; Takano R; Yamanaka Y
    Biochem Pharmacol; 1987 Jun; 36(11):1781-5. PubMed ID: 3034288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.
    DeMet EM; Bell KM; Reist C; Gerner RH; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):315-29. PubMed ID: 1963694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imipramine binding to platelets of children with attention deficit disorder with hyperactivity.
    Weizman A; Bernhout E; Weitz R; Tyano S; Rehavi M
    Biol Psychiatry; 1988 Mar; 23(5):491-6. PubMed ID: 2830919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: an exploratory study of clinical heterogeneity.
    Carr V; Edwards J; Prior M
    Biol Psychiatry; 1988 Mar; 23(6):560-74. PubMed ID: 2833320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients.
    Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H
    Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of (3H)-imipramine binding sites on platelets of conduct-disordered children.
    Stoff DM; Pollock L; Vitiello B; Behar D; Bridger WH
    Neuropsychopharmacology; 1987 Dec; 1(1):55-62. PubMed ID: 2855302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet 3H-imipramine binding in psychogenic pain patients.
    Mellerup ET; Bech P; Hansen HJ; Langemark M; Loldrup D; Plenge P
    Psychiatry Res; 1988 Nov; 26(2):149-56. PubMed ID: 2853399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet imipramine binding in intensive care unit suicidal patients.
    De Leo D; Caneva A; Marazziti D; Conti L
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):85-7. PubMed ID: 1657200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imipramine binding in depressive patients diagnosed according to different criteria.
    Plenge P; Mellerup ET; Gjerris A
    Acta Psychiatr Scand; 1988 Aug; 78(2):156-61. PubMed ID: 2851919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet MAO-B activity as a marker of behavioural characteristics in dementia disorders.
    Parnetti L; Reboldi GP; Santucci C; Santucci A; Gaiti A; Brunetti M; Cecchetti R; Senin U
    Aging (Milano); 1994 Jun; 6(3):201-7. PubMed ID: 7993928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High affinity 3H-imipramine binding in human platelets: age and sex effects.
    Baron M; Kowalik S; Barkai A; Gruen R
    Neuropsychobiology; 1984; 11(3):178-80. PubMed ID: 6089031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.